Sign in

CIK 0001787306

  • Large accelerated filer

Arcutis Biotherapeutics, Inc.

Sign in to watch
Ticker
ARQT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812974255
Phone
+1 805-418-5006
Business address
3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
Former names
Arcutis, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,253,826
in 9 filings, $2.1M under 10b5-1 plans

Net −$3,253,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-09-02 Krishnamohan Neha Director Grant or award · Stock Option (Right to Buy) +29,482 29,482
2022-08-18 Burnett Patrick Grant or award 10b5-1 +16,750 97,401
2022-08-15 Welgus Howard G. Director Sale −6,000 $24.80 $149K 174,208
2022-08-05 Watanabe Todd Franklin President and CEO Exercise or conversion +2,500 $1.68 $4K 654,371
2022-08-05 Watanabe Todd Franklin President and CEO Sale −2,500 $24.74 $62K 651,871
2022-08-05 Watanabe Todd Franklin President and CEO Exercise or conversion · Stock Option (Right to Buy) −2,500 109,348
2022-08-05 Frazier Life Sciences VIII, L.P. 10% owner Purchase +250,000 $20.00 $5.0M 8,684,232
2022-07-18 Welgus Howard G. Director Sale −6,000 $24.40 $146K 180,208
2022-07-08 OSBORNE DAVID W Chief Technical Officer Sale −2,197 $25.41 $56K 256,649
2022-07-08 Watanabe Todd Franklin President and CEO Sale −1,500 $25.00 $38K 656,784
2022-07-08 Watanabe Todd Franklin President and CEO Sale −4,913 $25.41 $125K 651,871
2022-07-08 Watanabe Todd Franklin President and CEO Exercise or conversion +7,087 $1.68 $12K 658,958
2022-07-08 Watanabe Todd Franklin President and CEO Sale −7,087 $25.41 $180K 651,871
2022-07-08 Watanabe Todd Franklin President and CEO Exercise or conversion · Stock Option (Right to Buy) −7,087 111,848
2022-07-06 Watanabe Todd Franklin President and CEO Sale −1,000 $22.07 $22K 658,284
2022-06-24 ORBIMED ADVISORS LLC 10% owner Sale −306,027 $21.31 $6.5M 3,534,537
2022-06-24 ORBIMED ADVISORS LLC 10% owner Sale −35,944 $21.31 $766K 415,142
2022-06-23 Watanabe Todd Franklin President and CEO Gift −268,964 382,907
2022-06-06 Watanabe Todd Franklin President and CEO Sale −1,000 $21.06 $21K 659,284
2022-06-02 Matsuda Masaru SVP and General Counsel Sale −1,795 $19.73 $35K 16,380

Page 28 of 35 · 689 trades